GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


Early stopping rules in clinical trials


Eu2P Short Course: Early stopping rules in clinical trials

OBJECTIVES

This course intends to question when to stop a clinical trial considering clinical, economic and also ethical concerns.

  • On one hand, to continue a clinical trial aiming to obtain full information on the main clinical variables can be desirable from a clinical point of view, but can be economic and time consuming or even unethical for patients not treated with the experimental intervention.
  • On the other hand, early stopping of a trial at interim analysis can raise concerns about the possibility of missing information on some benefit and harm variables and to overestimate treatment effects.

Clinical variables, Economic, Time consuming, Unethical, Intervention, Overestimate effect

 

LEARNING OUTCOMES

At the end of this course, you will be familiar with some early stopping rules in order to understand how to minimise the limitations of this strategy.

 

120 minutes
Online based learning
English language
Certificate of Achievement
200 €
REGISTER NOW

AUTHORS

avatar

Josep Maria Castel

Universitat Autònoma de Barcelona

avatar

Dr. Antònia Agustí

Universitat Autònoma de Barcelona


avatar

Dr. Xavier Vidal

Universitat Autònoma de Barcelona

avatar

Dr. Montse Bosch

Doctor of Medecine
Universitat Autònoma de Barcelona




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners